Weissman

Accelerator Corp. hatches Oncofactor, a new Seattle cancer research startup

Accelerator Corp. has backed its 12th startup, a cancer research company that’s attempting to disrupt signaling pathways between tumors and the immune system. Dubbed Oncofactor, the company is just getting off the ground. But investors, including Carl Weissman of the biotech incubator Accelerator and Chad Waite of OVP, are bullish on the concept. “The Oncofactor technology platform… Read More

koronis111

HIV drug maker Koronis considers IPO in London

We’ve bemoaned the fact that very few Seattle area companies are considering initial public offerings. But Koronis Pharmaceuticals, a Seattle company led by venture capitalist Donald Elmer, is positioning for an IPO in London either this year or next, Reuters reports. It would be a modest amount. Elmer tells Reuters that the company needs about… Read More